Sernova Biotherapeutics Aktie - SVA

Sernova Biotherapeutics Inc (SVA) Aktie

Professionelle Tools für Privatanleger.

Premium

Current Price

0,16

( -5,88% )

Gebot

0,15

Fragen

0,16

Volumen

121.662

0,155 Tagesbereich 0,17

0,12 52-Wochen-Bereich 0,21

Marktkapitalisierung

60,32M

Handelsende

0,17

Handelsbeginn

0,17

Letzte Trade

4000

0.16

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

$ 117.360

Ausgegebene Aktien

377.000.009

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-4,08

Gewinn pro Aktie (EPS)

-0,04

Erlöse (LTM)

Nettogewinn (LTM)

-11,91M

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longe... Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada. Mehr anzeigen

Sektor

Healthcare

Branche

Biotechnology & Life Sciences

Website

www.sernova.com

Hauptsitz

Mississauga, Canada

Gegründet

Sernova Biotherapeutics Inc is listed in the Healthcare sector of the Toronto Börse with ticker SVA. The last closing price for Sernova Biotherapeutics was $0,17. Over the last year, Sernova Biotherapeutics shares have traded in a share price range of $ 0,12 to $ 0,21.

Sernova Biotherapeutics currently has 377.000.009 shares in issue. The market capitalisation of Sernova Biotherapeutics is $60,32 million. Sernova Biotherapeutics has a price to earnings ratio (PE ratio) of -4.08.

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. (“Sernova” or the...

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford...

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB:...

Sernova Appoints Jonathan Rigby as Interim Chair

LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Chair of Sernova Biotherapeutics Resigns

LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

LONDON, Ontario and BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

Clinical Study on Track to Meet its Primary and Secondary Endpoints Data Demonstrate That Metabolic Measures...

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

DSMB supports advancement for Sernova’s clinical trial Study is on track to meet key clinical trial endpoints...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.005	3.22580645161	0.155	0.17	0.14	144660	0.15867251	CS
4	0.01	6.66666666667	0.15	0.17	0.135	129118	0.15020295	CS
12	0.005	3.22580645161	0.155	0.2	0.135	125163	0.1625739	CS
26	0.03	23.0769230769	0.13	0.2	0.12	117658	0.1578833	CS
52	-0.005	-3.0303030303	0.165	0.21	0.12	109973	0.16127435	CS
156	-0.71	-81.6091954023	0.87	1.1	0.12	128692	0.33556273	CS
260	-1.39	-89.6774193548	1.55	1.59	0.12	126903	0.50268247	CS

SVA - Frequently Asked Questions (FAQ)

What is the current Sernova Biotherapeutics Inc share price?

The current share price of Sernova Biotherapeutics Inc is $ 0,16

How many Sernova Biotherapeutics Inc shares are in issue?

Sernova Biotherapeutics Inc has 377.000.009 shares in issue

What is the market cap of Sernova Biotherapeutics Inc?

The market capitalisation of Sernova Biotherapeutics Inc is CAD 60,32M

What is the 1 year trading range for Sernova Biotherapeutics Inc share price?

Sernova Biotherapeutics Inc has traded in the range of $ 0,12 to $ 0,21 during the past year

What is the PE ratio of Sernova Biotherapeutics Inc?

The price to earnings ratio of Sernova Biotherapeutics Inc is -4,08

What is the registered address of Sernova Biotherapeutics Inc?

The registered address for Sernova Biotherapeutics Inc is RPO Central Parkway, Mississauga, Ontario, L5A 4H2

What is the Sernova Biotherapeutics Inc website address?

The website address for Sernova Biotherapeutics Inc is www.sernova.com

Which industry sector does Sernova Biotherapeutics Inc operate in?

Sernova Biotherapeutics Inc operates in the Biotechnology & Life Sciences sector

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Biotherapeutics Inc (SVA)

Sernova Biotherapeutics Inc (SVA) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Sernova Biotherapeutics Inc

SVA Neueste Nachrichten

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

Sernova Appoints Jonathan Rigby as Interim Chair

Chair of Sernova Biotherapeutics Resigns

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

SVA - Frequently Asked Questions (FAQ)

SVA Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sernova Biotherapeutics Inc (SVA)

Sernova Biotherapeutics Inc (SVA) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Sernova Biotherapeutics Inc

SVA Neueste Nachrichten

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

Sernova Appoints Jonathan Rigby as Interim Chair

Chair of Sernova Biotherapeutics Resigns

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

SVA - Frequently Asked Questions (FAQ)

SVA Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen